financetom
Business
financetom
/
Business
/
Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Increase
Jul 30, 2024 2:49 PM

05:16 PM EDT, 07/30/2024 (MT Newswires) -- Houlihan Lokey ( HLI ) reported fiscal Q1 adjusted earnings late Tuesday of $1.22 per diluted share, up from $0.89 a year earlier.

Analysts polled by Capital IQ expected $1.20.

Revenue for the quarter ended June 30 was $513.6 million, up from $415.8 million a year earlier.

Analysts surveyed by Capital IQ expected $508.7 million.

The company said its board maintained its quarterly dividend at $0.57 per share, payable Sept. 15 to shareholders of record on Sept. 3.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada Nickel to Spin Out Net Smelter Returns on Certain Properties
Canada Nickel to Spin Out Net Smelter Returns on Certain Properties
Mar 18, 2025
08:35 AM EDT, 03/18/2025 (MT Newswires) -- Canada Nickel ( CNIKF ) on Tuesday said it created a new royalty company to hold net smelter return (NSR) royalties on most of its regional exploration properties in the Timmins Nickel district. The company signed a binding letter of intent with Edmiston Drive Capital (EDCC) to create the new company called RoyaltyCo....
Alphabet's Google Agrees to Acquire Wiz for $32 Billion
Alphabet's Google Agrees to Acquire Wiz for $32 Billion
Mar 18, 2025
08:37 AM EDT, 03/18/2025 (MT Newswires) -- Alphabet's (GOOG) Google ( GOOG ) said Tuesday it has signed a definitive agreement to acquire New York-based cloud security platform Wiz for $32 billion. Once the all-cash deal is closed, Wiz will join Google Cloud, the company said. ...
Ocugen Advances OCU200 Trial After Safety Board Review
Ocugen Advances OCU200 Trial After Safety Board Review
Mar 18, 2025
08:30 AM EDT, 03/18/2025 (MT Newswires) -- Ocugen ( OCGN ) said Tuesday that an independent safety board reviewed data from the first dosing group in its phase 1 trial of OCU200 for diabetic macular edema and approved advancing to the second group. The company said the trial is testing OCU200, a fusion protein combining two human proteins, in patients...
Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy
Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy
Mar 18, 2025
08:37 AM EDT, 03/18/2025 (MT Newswires) -- Actinium Pharmaceuticals ( ATNM ) said Tuesday it is launching a clinical program consisting of trials studying Actimab-A in combination with either Merck's ( MRK ) Keytruda or Bristol Myers Squibb's ( BMY ) Opdivo for the treatment of multiple solid tumors. Actimab-A is meant to improve the efficacy of the immunotherapies by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved